Summary

Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system. Delivering drugs to the brain remains one of the greatest challenges in pharmaceutical research, as the blood-brain barrier prevents many compounds from entering the central nervous system.

AI summaries can be wrong sometimes—always verify important details using the source article.